$2.11
14.23% today
Nasdaq, Dec 30, 09:48 pm CET
ISIN
US09060U5074
Symbol
BCDA
Sector
Industry

BioCardia Inc. Target price 2024 - Analyst rating & recommendation

BioCardia Inc. Classifications & Recommendation:

Buy
100%

BioCardia Inc. Price Target

Target Price $25.00
Price $2.46
Potential
Number of Estimates 1
1 Analyst has issued a BioCardia Inc. price target 2025. The average BioCardia Inc. target price is $25.00. This is higher than the current stock price.
A rating was issued by 1 analysts: 1 Analysts recommend BioCardia Inc. to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the BioCardia Inc. stock has an average upside potential 2025 of . Most analysts recommend the BioCardia Inc. stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 0.48 0.10
64.44% 79.17%
EBITDA Margin -2,339.58% -9,700.00%
174.17% 314.60%

1 Analyst has issued a sales forecast BioCardia Inc. 2024 . The average BioCardia Inc. sales estimate is

$100k
Unlock
. This is
42.86% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$100k 42.86%
Unlock
, the lowest is
$100k 42.86%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $480k 64.44%
2024
$100k 79.17%
Unlock
2025
$100k 0.00%
Unlock
2026
$100k 0.00%
Unlock
2027
$100k 0.00%
Unlock
2028
$8.4m 8,300.00%
Unlock

1 Analyst has issued an EBITDA forecast BioCardia Inc. 2024 . The average BioCardia Inc. EBITDA estimate is

$-9.7m
Unlock
. This is
32.15% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-9.7m 32.15%
Unlock
, the lowest is
$-9.7m 32.15%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $-11.2m 2.52%
2024
$-9.7m 13.62%
Unlock
2025
$-11.0m 13.40%
Unlock
2026
$-13.1m 19.09%
Unlock
2027
$-16.1m 22.90%
Unlock
2028
$-14.2m 11.80%
Unlock

EBITDA Margin

2023 -2,339.58% 174.17%
2024
-9,700.00% 314.60%
Unlock
2025
-11,000.00% 13.40%
Unlock
2026
-13,100.00% 19.09%
Unlock
2027
-16,100.00% 22.90%
Unlock
2028
-169.05% 98.95%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
EV/Sales 74.00

Based on analysts' sales estimates for 2024, the BioCardia Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

74.00
Unlock
and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of
112.80
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 105.71 342.67%
2024
74.00 30.00%
Unlock
2025
74.00 0.00%
Unlock
2026
74.00 0.00%
Unlock
2027
74.00 0.00%
Unlock
2028
0.88 98.81%
Unlock

P/S ratio

Current 161.14 553.75%
2024
112.80 30.00%
Unlock
2025
112.80 0.00%
Unlock
2026
112.80 0.00%
Unlock
2027
112.80 0.00%
Unlock
2028
1.34 98.81%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today